Article Details

Intellia, Cellex form CAR T cell therapy newco backed by $250M from Blackstone

Retrieved on: 2021-06-22 17:48:45

Tags for this article:

Click the tags to see associated articles and topics

Intellia, Cellex form CAR T cell therapy newco backed by $250M from Blackstone. View article details on hiswai:

Excerpt

... Intellia sees technology from clinical-stage GEMoaB as a potential solution, and it is forming a new company that will pair their respective platforms.

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up